Migraine vs. Epilepsy: Overlap, Differences, and Comorbidity

Key Distinctions

FeatureMigraineEpileptic Seizure
Core phenomenonCortical spreading depression (CSD) + trigeminovascular activationAbnormal hypersynchronous neuronal discharge
HeadacheCentral feature (moderate-severe, throbbing)May occur post-ictally (post-ictal headache)
Duration4–72 hours (untreated)Seconds to minutes (status epilepticus >5 min)
ConsciousnessPreserved (except hemiplegic migraine, confusional migraine)Often impaired (except focal aware seizures)
Motor phenomenaRare (hemiplegic migraine)Common: tonic-clonic, myoclonic, tonic, atonic
AuraGradual onset (5–60 min), positive visual/sensory/speech symptomsInstantaneous; may be experiential (déjà vu, fear, epigastric rising)
EEGNormal or nonspecific slowingIctal epileptiform discharges (not always captured)
TreatmentTriptans, gepants, CGRP mAbs, preventivesAntiseizure medications (ASMs), surgery, devices

Comorbidity & Bidirectional Risk

  • People with epilepsy: 2–3× higher migraine prevalence (~24% vs. 12% general).
  • People with migraine: 2× higher epilepsy risk.
  • Shared genetic susceptibility (CACNA1A, SCN1A, ATP1A2, PRRT2).
  • Shared triggers: sleep deprivation, stress, alcohol, flashing lights.

Diagnostic Challenges

  • Migralepsy: Seizure triggered by migraine aura (ICHD-3: "migraine aura-triggered seizure").
  • Hemiplegic migraine vs. Todd's paresis: Both cause transient hemiparesis; history, EEG, genetics differentiate.
  • Visual aura vs. occipital seizure: Aura = gradual, positive symptoms; seizure = instantaneous, often negative/forced deviation.
  • Syncope vs. seizure vs. migraine: Provocation, prodrome, post-event state differ.

Shared Treatment Opportunities

  • Topiramate, valproate: FDA-approved for both migraine prevention and epilepsy.
  • CGRP mAbs: No seizure worsening signal; safe in comorbidity.
  • Lifestyle: Sleep hygiene, stress management, trigger avoidance benefit both.
  • Caution: Some ASMs worsen migraine (carbamazepine, phenytoin); some migraine meds lower seizure threshold (bupropion, high-dose tramadol).

Clinical Approach

  1. Detailed event history (witness account ideal).
  2. EEG (routine + sleep-deprived) if seizure suspected.
  3. MRI brain (epilepsy protocol) for structural lesions.
  4. Genetic panel if early onset, family history, or atypical features.
  5. Treat both conditions with compatible medications; monitor for interactions.

Migraine - Related Articles